Nakatsumi H - Search Results

1

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.

Nakatsumi H, Komatsu Y, Yuki S, Sogabe S, Tateyama M, Muto S, Kudo M, Kato K, Miyagishima T, Uebayashi M, Meguro T, Oba K, Asaka M. Nakatsumi H, et al. Chemotherapy. 2012;58(6):439-44. doi: 10.1159/000345920. Epub 2013 Jan 29. Chemotherapy. 2012. PMID: 23364217 Clinical Trial.

2

[A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs].

Sogabe S, Yuki S, Takagi T, Miyazaki T, Takano H, Kawamoto Y, Nakatsumi H, Sasaki T, Iwanaga I, Uehata Y, Asaka M, Komatsu Y. Sogabe S, et al. Among authors: nakatsumi h. Gan To Kagaku Ryoho. 2010 Mar;37(3):535-8. Gan To Kagaku Ryoho. 2010. PMID: 20332699 Japanese.

3

[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].

Sogabe S, Yuki S, Takano H, Kobayashi Y, Nakatsumi H, Sasaki T, Kawamoto Y, Fukushima H, Iwanaga I, Uehata Y, Komatsu Y, Asaka M. Sogabe S, et al. Among authors: nakatsumi h. Gan To Kagaku Ryoho. 2011 Aug;38(8):1375-7. Gan To Kagaku Ryoho. 2011. PMID: 21829085 Review. Japanese.

4

[Colorectal cancer chemotherapy and QOL (benefits and problems of outpatient-chemotherapy)].

Nakatsumi H, Yuki S, Kobayashi Y, Komatsu Y. Nakatsumi H, et al. Nihon Rinsho. 2011 Apr;69 Suppl 3:585-8. Nihon Rinsho. 2011. PMID: 22214028 Review. Japanese. No abstract available.

5

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.

Komatsu Y, Yuki S, Sogabe S, Fukushima H, Nakatsumi H, Kobayashi Y, Iwanaga I, Nakamura M, Hatanaka K, Miyagishima T, Kudo M, Munakata M, Meguro T, Tateyama M, Sakata Y. Komatsu Y, et al. Among authors: nakatsumi h. Acta Oncol. 2012 Sep;51(7):867-72. doi: 10.3109/0284186X.2012.682629. Epub 2012 May 4. Acta Oncol. 2012. PMID: 22554343 Free article. Clinical Trial.

6

[Gastrointestinal ulcer, gastrointestinal perforation].

Nakatsumi H, Komatsu Y. Nakatsumi H, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:380-3. Nihon Rinsho. 2015. PMID: 25831787 Japanese. No abstract available.

7

Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center Experience.

Muranaka T, Yuki S, Komatsu Y, Sawada K, Harada K, Kawamoto Y, Nakatsumi H, Sakamoto N. Muranaka T, et al. Among authors: nakatsumi h. J Gastric Cancer. 2016 Sep;16(3):177-181. doi: 10.5230/jgc.2016.16.3.177. Epub 2016 Sep 30. J Gastric Cancer. 2016. PMID: 27752395 Free PMC article.

8

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.

Muranaka T, Kuwatani M, Komatsu Y, Sawada K, Nakatsumi H, Kawamoto Y, Yuki S, Kubota Y, Kubo K, Kawahata S, Kawakubo K, Kawakami H, Sakamoto N. Muranaka T, et al. Among authors: nakatsumi h. J Gastrointest Oncol. 2017 Jun;8(3):566-571. doi: 10.21037/jgo.2017.02.02. J Gastrointest Oncol. 2017. PMID: 28736643 Free PMC article.

9

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.

Kawamoto Y, Komatsu Y, Yuki S, Sawada K, Muranaka T, Harada K, Nakatsumi H, Fukushima H, Ishiguro A, Dazai M, Hatanaka K, Nakamura M, Iwanaga I, Uebayashi M, Sogabe S, Kobayashi Y, Miyagishima T, Ono K, Sakamoto N, Sakata Y. Kawamoto Y, et al. Among authors: nakatsumi h. BMC Cancer. 2017 Dec 8;17(1):837. doi: 10.1186/s12885-017-3850-z. BMC Cancer. 2017. PMID: 29221445 Free PMC article. Clinical Trial.

10

Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.

Masuishi T, Taniguchi H, Kawakami T, Kawamoto Y, Kadowaki S, Onozawa Y, Muranaka T, Tajika M, Yasui H, Nakatsumi H, Yuki S, Muro K, Omae K, Komatsu Y, Yamazaki K. Masuishi T, et al. Among authors: nakatsumi h. ESMO Open. 2019 Nov;4(6):e000584. doi: 10.1136/esmoopen-2019-000584. ESMO Open. 2019. PMID: 32392174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters